United States - English - NLM (National Library of Medicine)

symbiopathic - penicillium glabrum (unii: 2in23yue0i) (penicillium glabrum - unii:2in23yue0i) - this remedy is indicated for symptoms associated with colds; flu, inflamed nasal passages, pre- and post- influenza neuralgia, laryngitis, sinusitis and myalgias according to traditional homeopathic practice.* for internal indications according to traditional homeopathic practice.

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 10000 [pnu] in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - rumex acetosella pollen (unii: n52miq81zw) (rumex acetosella pollen - unii:n52miq81zw), rumex crispus pollen (unii: v825xjg64g) (rumex crispus pollen - unii:v825xjg64g) - alternaria alternata 0.1 g in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - sarocladium strictum (unii: 3f36v0451w) (sarocladium strictum - unii:3f36v0451w) - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - fludioxonil - suspension concentrate - fludioxonil phenylpyrrole active 230.0 g/l - fungicide - apricot | citrus | kiwi fruit | peach | pome fruit | stone fruit (see label for exceptions) | apple | chinese gooseberry | grape - blue mould on citrus - p. italicum | blue mould on pome - p. expansum | brown rot - monilinia spp. | green mould | grey mould - botrytis cinerea | pome fruit - penicillium solitum | rhizopus soft rot | stem end rot - diplodia natalensis | blossom blight | botrytis blight | botrytis rot | bunch rot

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - fludioxonil - suspension concentrate - fludioxonil phenylpyrrole active 100.0 g/l - fungicide - maize | potato | sweet corn | sweetcorn - anthracnose - colletotrichum coccodes | black stem canker scurf | common potato scab - suppression of seed | fusarium dry rot | fusarium spp. | penicillium spp. | silver scurf | black dot | black scurf | canker | common potato scab-seed borne | damping off | fusarium patch | hypocotyl rot | root rot | soil fungi | wire stem

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

syngenta australia pty ltd - thiabendazole - suspension concentrate - thiabendazole thiazole active 500.0 g/l - fungicide - apple | banana | bulb | citrus | corm | mushroom casing | mushroom crop | potato | turf | delicious | golden delicious | granny - anthracnose, blackend or crown rot | blue mould | blue mould on citrus - p. italicum | crown rot | crown rot - verticillium spp. | deightoniella spp. | dollar spot | fruit rot or spot | fusarium basal rot | fusarium dry rot | fusarium patch | fusarium spp. | gangrene - phoma exigua | green mould | grey mould - botrytis cinerea | penicillium blue mould | silver scurf | squirter | stem end rot - phomopsis citri | wet bubble disease on mushroom | black-end rot | botrytis blight | botrytis rot | bunch rot | fusarium patch | melanose | stem-end rot

New Zealand - English - Medsafe (Medicines Safety Authority)

ebos group ltd - allergen extracts 100 pnu/ml (alternaria, aspergillus, cladosporium, penicillium); allergen extracts 1000 pnu/ml (alternaria, aspergillus, cladosporium, penicillum,); allergen extracts 10000 pnu/ml (alternaria, aspergillus, cladosporium, penicillum,) - suspension for injection - active: allergen extracts 100 pnu/ml (alternaria, aspergillus, cladosporium, penicillium) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 1000 pnu/ml (alternaria, aspergillus, cladosporium, penicillum,) excipient: aluminium hydroxide phenol sodium chloride water for injection active: allergen extracts 10000 pnu/ml (alternaria, aspergillus, cladosporium, penicillum,) excipient: aluminium hydroxide phenol sodium chloride water for injection

United States - English - NLM (National Library of Medicine)

sanpharma gmbh - penicillium roqueforti (unii: 7orp6r724l) (penicillium roqueforti - unii:7orp6r724l) - for intestinal symptoms

United States - English - NLM (National Library of Medicine)

jubilant hollisterstier llc - bos taurus hair (unii: toq97z8644) (bos taurus hair - unii:toq97z8644), bos taurus dander (unii: c8vys726o8) (bos taurus dander - unii:c8vys726o8) - equus caballus hair 0.01 g in 1 ml - non-standardized allergenic extracts are indicated for: - skin test diagnosis of individuals with a clinical history of allergy to the specific corresponding allergens. non-standardized allergenic extracts are indicated for: - immunotherapy for the reduction of allergen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for allergen specific ige antibodies for the specific corresponding allergens. non-standardized allergenic extracts are contraindicated in individuals with the following conditions: - severe, unstable or uncontrolled asthma. - history of any severe systemic reaction to the allergen extract when administered for diagnosis or treatment. - medical conditions that reduce the ability to survive anaphylaxis. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respecti